Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 08 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 May 2018.
- 12 Jul 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Nov 2017.